bck_fil.gif (53 bytes)
Home

 

Indice/Contents Nº 6


EFICACIA DE F18 – FLUORODEOXIGLUCOSA SPECT PARA EVALUAR INFARTO RECIENTE Y VIABILIDAD MIOCARDICA

 

BIBLIOGRAFIA:

1.

Anuario de Demografía INE, Ministerio de Salud de Chile 1989, página 347.

2.

Braunwald E, Kloner RA. The stunned myocardium: Prolonged postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149

3.

Reibel DK, Rovetto JJ. Myocardial ATP synthesis and mechanical function following oxygen deficiency. Am J Physiol 1978; 234:620.

4.

Jennings RB. Early phase of myocardial ischemic injury and infarction. Am J Cardiol 1969; 24: 753.

5.

Kniekelbien T, Sagar KB, Carlos ME, Wynson JC, Smart SC. Viability of dobutamine echocardiography identifies whose outcome is improved by elective revascularization after acute infarction. J Am Coll Cardiol; 1995: 5a (abstract)

6.

Lee KS, Marwek TH, Cook SA, Go RT, Fix JS, James KB. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation 1994; 90: 2687 – 26964

7.

Pierard L, De Landsheere C, Berthe C, Rigo P, Kulbertus H. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. JACC 1990: 1021 – 31

8.

Smartirt SC, Knickelbien T, Carlos ME, Hellman RS. Dobutamine echocardiography and rest SPECT Tl 201 scintigraphy are more concordant in detecting viability in hibernating than stunned myocardium. JACC; 1995: Feb. 126a (abstract)

9.

Imaging guidelines for nuclear cardiology procedures Part 2, Ed S.C. Port J Nucl Cardiol 1999; 6(2): G47-84

10.

Colby J, Hakk AH, Iskandrian AS. Hemodynamic, angiographic and scintigraphic correlation of positive exercise electrocardiograms: emphasis on strongly positive exercise electrocardiograms. J Am Coll Cardiol 1983; 2: 21 – 27

11.

González P et al. Utilidad de la prueba de esfuerzo con Talio 201 en cardiopatía coronaria. Rev Med Chile 1982; 110: 839

12.

Rahimtoola SH. The hybernating myocardium. Am Heart J 1989; 177: 211 – 221

13.

Kobayashi H, Miyagi M, Nakajima H, Watanabe T, Nagai Y, Ibukiyama C. Evaluation of myocardial viability and efficacy of reperfusion therapy by dual – SPECT using 99mTc – PYP and 201Tl in acute myocardial infarction. Kaku Igaku 1994; 31(10): 1227 – 36

14.

Dilsizian V, Rocco T, Freedman N et al. Enhanced detection of ischemic viable myocardium by the reijection of thallium after stress – redistribution imaging. N Engl J Med 1990; 323: 141 – 146

15.

Darcourt J, He ZX, Guigneir A, Ferrari E, Baudouy M, Morand P, Bussiere F, Mena I. Nitroglicerine enhanced thallium – 201 reinjection for the detection of viable myocardium. J Nucl Med 1993; 34(5): 45P

16.

Beller George A. Myocardial Thallium – 201 imaging for detection of myocardial viability in " Nuclear Cardiology. State of the art and future directions". Barry L. Zaret and George Beller, Cap 21 pag 227 – 235. Mosby Ed 1993, Missouri.

17.

Iskandrian A, Hakki A, Kane et al. Rest and redistribution thallium myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983; 51: 1312 – 1316

18.

Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO. Concordance and discordance between stress-redistribution-reinjection and rest-resistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993 Sep. ; 88(3): 283 – 93

19.

Inglese E, Brambilla M, Dondi M et al. Assessment of myocardial viability after Thallium 201 reinjection or rest-redistribution imaging: A multicenter study. J Nucl Med 1995; 36: 555 – 563

20.

Lomboy CT, Schulman DS, Grill HP et al. Rest-redistribution Thallium 201 scintigraphy to determine myocardial viability early after myocardial infarction. J Am Coll Cardiol 1995; 25: 210 – 217

21.

Mori T, Minamiji K, Kurogane H et al. Rest-injected Thallium 201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991; 32: 1718 – 24

22.

Ragosta M, Beller GA, Watson DD el al. Quantitative planar rest-redistribution 201-Thallium imaging in the detection of myocardial viability prediction of improvement i left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1995; 87: 1630 – 41

23.

Ohtani H, Tamaki N, Yonekura Y, Mohiuddin I et al. Value of thallium 201 reinjection after delayed a SPECT imaging for predicting reversible ischemia after coronary bypass grafting. Am J Cardiol 1990; 66: 394 – 399

24.

Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H et al. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET. J Cardiol 1992; 22 (2-3): 283 – 93

25.

Barstentein P, Hasfeld M, Schober O, Matheja P et al. Tl – 201 reinjection and improvement of left ventricular function following revascularization. J Nucl Med 1993; 34 (5): 45P abstract 172

26.

Bax J, Visser F, Van Lingen A, Kamp O et al. Feasibility of assessing regional myocardial uptake of F-18 fluorodeoxyglucose using Single Photon Emission Computed Tomography. Eur Heart J 1993; 14: 1675 – 82

27.

Gallagher BM, Fowler JS, Gutterson NI et al. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of 18-FDG. J Nucl Med 1978; 19: 1154 – 61

28.

Phelps ME, Hoffman EJ, Selin C et al. Investigation of 18-FDG for measurement of myocardial glucose metabolism. J Nucl Med 1978; 19: 1131 – 39

29.

Schwaiger M et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by PET. J Am Coll Cardiol 1986; 8: 800

30.

Minn H, Joensuu H, Ahonen A, Klemi P. Fluordeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer b1988; 61: 1776 – 81

31.

Hoeflin F, Ledermann H, Noelpp U, Weinrich R, Roesler H. Routine 18-F deoxi-2-fluoro-d-glucose (18-FDG) myocardial tomography ussing normal large field of view gammacamera. Angiology 1989; 140: 1058 – 64

32.

Van Lingen A, Huijgens PC, Visser FC et al. Performance characteriscs of a 511 KeV collimator for imaging positron emitters with standard gammacamera. Eur J Nucl Med 1992; 19: 315 – 21

33.

Willians K, Tailon LA, Stark VJ. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium 201 perfusion defects in patients with myocardial infarction: comparision with late (24 hours) redistribution thallium imaging for detection of reversible ischemia. Am Heart J 1992; 124: 194 – 304

34.

Draen W, Abbott F, Nicole M, Mastin S, Kuperus J. Technology for FDG SPECT with a relatively inexpensive gammacamera. Radiology 1994; 191(2): 461 – 65

35.

Burt RW, Perkins OW, Oppenheim BE et al. Comparision of F-18 FDG SOECT, F-18 FDG PET and rest thallium 201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36(2): 176 – 79

36.

Bax JM, Visser FC, Van Lingen A, Teule GJ, Visser CA. Serial assessment of metabolic and functional changes after acute myocardial infarction with planar 201 Tl/FDG imaging and echocardiography. J Nucl Cardiol 1995; 2(2): S2: S03 – 006


Resumen | Introducción | Material y Método | Resultados | Discusión | Bibliografía | Versión Completa | Portada Artículo